General Tachy
Total Payments
$819,167
Transactions
9
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $819,167 | 9 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $819,167 | 9 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| INSIGHT Collaborative Research Agreement | Boston Scientific Corporation | $783,334 | 0 |
| Heart Logic Guided optimization of CHF medications in Chronic low EF population | Boston Scientific Corporation | $22,833 | 0 |
| Assessing Pacing Strategies in Cardiac Amyloidosis | Boston Scientific Corporation | $13,000 | 0 |
Top Doctors Receiving Payments for General Tachy
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Nashville, TN | $819,167 | 9 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $819,167
Product Information
- Type Device
- Total Payments $819,167
- Total Doctors 0
- Transactions 9
About General Tachy
General Tachy is a device associated with $819,167 in payments to 0 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2023 to 2023. In 2023, $819,167 was paid across 9 transactions to 0 doctors.
The most common payment nature for General Tachy is "Unspecified" ($819,167, 100.0% of total).
General Tachy is associated with 3 research studies, including "INSIGHT Collaborative Research Agreement" ($783,334).